Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Receptors, CXCR

FacultyTitle
3Conformational selection guides β-arrestin recruitment at a biased G protein-coupled receptor. (Kleist AB, Jenjak S, Sente A, Laskowski LJ, Szpakowska M, Calkins MM, Anderson EI, McNally LM, Heukers R, Bobkov V, Peterson FC, Thomas MA, Chevigné A, Smit MJ, McCorvy JD, Babu MM, Volkman BF) Science 2022 Jul 08;377(6602):222-228       14 Citations
3The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3. (Wedemeyer MJ, Mahn SA, Getschman AE, Crawford KS, Peterson FC, Marchese A, McCorvy JD, Volkman BF) J Biol Chem 2020 Oct 02;295(40):13927-13939       8 Citations
2A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration. (Lau S, Feitzinger A, Venkiteswaran G, Wang J, Lewellis SW, Koplinski CA, Peterson FC, Volkman BF, Meier-Schellersheim M, Knaut H) Nat Cell Biol 2020 Mar;22(3):266-273       37 Citations
1Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on 13C-methyl methionine labeling of the atypical chemokine receptor ACKR3. (Kleist AB, Peterson F, Tyler RC, Gustavsson M, Handel TM, Volkman BF) Methods Cell Biol 2019;149:259-288       8 Citations
1Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. (Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M) PLoS One 2018;13(9):e0204041       5 Citations
1Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. (Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M) Open Biol 2018 Jan;8(1)       20 Citations
1Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. (Szpakowska M, Nevins AM, Meyrath M, Rhainds D, D'huys T, Guité-Vinet F, Dupuis N, Gauthier PA, Counson M, Kleist A, St-Onge G, Hanson J, Schols D, Volkman BF, Heveker N, Chevigné A) Br J Pharmacol 2018 May;175(9):1419-1438       48 Citations
1Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. (Cheng YH, Eby JM, LaPorte HM, Volkman BF, Majetschak M) PLoS One 2017;12(11):e0187949       15 Citations
1α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. (Albee LJ, Eby JM, Tripathi A, LaPorte HM, Gao X, Volkman BF, Gaponenko V, Majetschak M) J Am Heart Assoc 2017 Aug 17;6(8)       29 Citations
1New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. (Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M) Int J Mol Sci 2016 Jun 20;17(5)       31 Citations
1Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function. (Bach HH 4th, Wong YM, Tripathi A, Nevins AM, Gamelli RL, Volkman BF, Byron KL, Majetschak M) Mol Med 2014 Oct 13;20(1):435-47       32 Citations
2CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. (Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB) PLoS One 2014;9(3):e90400       73 Citations
1CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin. (Tripathi A, Davis JD, Staren DM, Volkman BF, Majetschak M) Cytokine 2014 Feb;65(2):121-5       28 Citations
2Sulfotyrosine recognition as marker for druggable sites in the extracellular space. (Ziarek JJ, Heroux MS, Veldkamp CT, Peterson FC, Volkman BF) Int J Mol Sci 2011;12(6):3740-56       16 Citations